BOLT — Bolt Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Bolt Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	22.8	186	169	102	47.3
Net Total Receivables	—	—	—	—	1.17
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25.4	189	173	106	50.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.4	30.6	28.5	24.1	24.9
Long Term Investments
Other Long Term Assets
Total Assets	46.5	308	228	160	99.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.3	21.3	23.1	20.5	15.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	46.2	57.6	56.3	47	42.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.349	250	172	113	57.2
Total Liabilities & Shareholders' Equity	46.5	308	228	160	99.6
Total Common Shares Outstanding